Answer
Renal impairment does not substantially change its pharmacokinetics, although severe impairment warrants clinical monitoring. Use is not recommended in severe hepatic impairment.
Sources for this answer
- Rizmoic 200 micrograms film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.